What is NDC 85477-327?

85477-327 is the product NDC for Spravex, Lidocaine 41.2 mg/mL spray, listed with the FDA by Oncora Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Oncora Pharma, LLC, NDC labeler code 85477. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Spravex?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Spravex NDC 85477-327 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85477-327Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85477-0327Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85477-327-29	8547703272985477032729	30 mL in 1 BOTTLE, SPRAY (85477-327-29)Marketed from Oct 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Spravex
Generic name (nonproprietary): spravex
Active ingredients: Lidocaine — 41.2 mg/mL
Dosage form: Spray
Route: Topical
Labeler: Oncora Pharma, LLCNDC labeler code 85477
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Oct 20, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 85477-327_aa031861-2cc0-4a56-b60a-2d5215576d36SPL ID aa031861-2cc0-4a56-b60a-2d5215576d36SPL set ID 57fd8178-0d7d-4dfa-8669-26908c4acf80RxCUI 2749997UNII 98PI200987UPC 0854770327290
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485477032729 followed by a unit qualifier and the quantity

Package 85477-0327-29. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Spravex™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 85477-327

What is NDC 85477-327?: 85477-327 is the product NDC for Spravex, Lidocaine 41.2 mg/mL spray, listed with the FDA by Oncora Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Spravex.
What is the active ingredient?: Lidocaine.
Who is the labeler?: Oncora Pharma, LLC, NDC labeler code 85477. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Spravex?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.